SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-013140
Filing Date
2018-05-16
Accepted
2018-05-16 21:25:40
Documents
1
Period of Report
2018-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6303
  Complete submission text file 0000899243-18-013140.txt   7851
Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
BLUM LEONARD M (Reporting) CIK: 0001222247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 18841575

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments